ATE249233T1 - Verwendung von gonadotropin releasing hormon analogen oder änlichen verbindungen zur herstellung von pharmazeutischen zubereitungen als zusatz für invasiver behandlung von karzinomen - Google Patents

Verwendung von gonadotropin releasing hormon analogen oder änlichen verbindungen zur herstellung von pharmazeutischen zubereitungen als zusatz für invasiver behandlung von karzinomen

Info

Publication number: ATE249233T1
Authority: AT; Austria
Prior art keywords: releasing hormone; production; carcinoma; additional; gonadotropin releasing
Prior art date: 1996-03-18

Application number

AT97104590T

Other languages

English (en)

Inventor

Gary D Hodgen

Original Assignee

Hampton Roads Medical College

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-18

Filing date

1997-03-18

Publication date

2003-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24472058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE249233(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-03-18 Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College

2003-09-15 Application granted granted Critical

2003-09-15 Publication of ATE249233T1 publication Critical patent/ATE249233T1/de

Links

XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical class C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title abstract 2
201000009030 Carcinoma Diseases 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
229940046085 endocrine therapy drug gonadotropin releasing hormone analogues Drugs 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
206010011732 Cyst Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
208000031513 cyst Diseases 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
230000002611 ovarian Effects 0.000 abstract 1
150000003431 steroids Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

AT97104590T 1996-03-18 1997-03-18 Verwendung von gonadotropin releasing hormon analogen oder änlichen verbindungen zur herstellung von pharmazeutischen zubereitungen als zusatz für invasiver behandlung von karzinomen ATE249233T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/617,048 US5691314A (en)	1996-03-18	1996-03-18	Adjunctive therapy

Publications (1)

Publication Number	Publication Date
ATE249233T1 true ATE249233T1 (de)	2003-09-15

Family

ID=24472058

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97104590T ATE249233T1 (de)	1996-03-18	1997-03-18	Verwendung von gonadotropin releasing hormon analogen oder änlichen verbindungen zur herstellung von pharmazeutischen zubereitungen als zusatz für invasiver behandlung von karzinomen

Country Status (7)

Country	Link
US (2)	US5691314A (de)
EP (1)	EP0796622B1 (de)
AT (1)	ATE249233T1 (de)
DE (1)	DE69724682T2 (de)
DK (1)	DK0796622T3 (de)
ES (1)	ES2206622T3 (de)
PT (1)	PT796622E (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5780435A (en)	1995-12-15	1998-07-14	Praecis Pharmaceuticals Incorporated	Methods for treating prostate cancer with LHRH-R antagonists
US6254601B1 (en)	1998-12-08	2001-07-03	Hysterx, Inc.	Methods for occlusion of the uterine arteries
US6550482B1 (en)	2000-04-21	2003-04-22	Vascular Control Systems, Inc.	Methods for non-permanent occlusion of a uterine artery
US7223279B2 (en)	2000-04-21	2007-05-29	Vascular Control Systems, Inc.	Methods for minimally-invasive, non-permanent occlusion of a uterine artery
US6638286B1 (en)	2000-11-16	2003-10-28	Vascular Control Systems, Inc.	Doppler directed suture ligation device and method
US6635065B2 (en) *	2000-11-16	2003-10-21	Vascular Control Systems, Inc.	Doppler directed suture ligation device and method
JP4227415B2 (ja)	2001-03-28	2009-02-18	ヴァスキュラー・コントロール・システムズ・インコーポレーテッド	子宮動脈を検知及び結紮する方法及び装置
US7354444B2 (en)	2001-03-28	2008-04-08	Vascular Control Systems, Inc.	Occlusion device with deployable paddles for detection and occlusion of blood vessels
US7207996B2 (en)	2002-04-04	2007-04-24	Vascular Control Systems, Inc.	Doppler directed suturing and compression device and method
US7172603B2 (en) *	2002-11-19	2007-02-06	Vascular Control Systems, Inc.	Deployable constrictor for uterine artery occlusion
US20040097961A1 (en) *	2002-11-19	2004-05-20	Vascular Control System	Tenaculum for use with occlusion devices
US7404821B2 (en)	2003-01-30	2008-07-29	Vascular Control Systems, Inc.	Treatment for post partum hemorrhage
US7651511B2 (en)	2003-02-05	2010-01-26	Vascular Control Systems, Inc.	Vascular clamp for caesarian section
US7333844B2 (en)	2003-03-28	2008-02-19	Vascular Control Systems, Inc.	Uterine tissue monitoring device and method
US7325546B2 (en) *	2003-11-20	2008-02-05	Vascular Control Systems, Inc.	Uterine artery occlusion device with cervical receptacle
US7686817B2 (en)	2003-11-25	2010-03-30	Vascular Control Systems, Inc.	Occlusion device for asymmetrical uterine artery anatomy
US20060015144A1 (en) *	2004-07-19	2006-01-19	Vascular Control Systems, Inc.	Uterine artery occlusion staple
US7875036B2 (en)	2004-10-27	2011-01-25	Vascular Control Systems, Inc.	Short term treatment for uterine disorder
WO2009043441A1 (en) *	2007-09-11	2009-04-09	Mondobiotech Laboratories Ag	D-ala-gln-octadecyl ester as a therapeutic agent
WO2009039983A2 (en) *	2007-09-11	2009-04-02	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
CN101555274B (zh) *	2009-05-15	2013-08-21	海南双成药业股份有限公司	一种多肽固相合成比法卢定粗品的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5116818A (en) *	1987-03-10	1992-05-26	Medical College Of Hampton Roads	Method and kit for contraception with GnRH-antagonist
ES2062628T3 (es) *	1990-08-04	1994-12-16	Hoechst Ag	Antagonistas de gonadoliberina.
US5780435A (en)	1995-12-15	1998-07-14	Praecis Pharmaceuticals Incorporated	Methods for treating prostate cancer with LHRH-R antagonists

1996
- 1996-03-18 US US08/617,048 patent/US5691314A/en not_active Expired - Lifetime
1997
- 1997-03-18 DE DE69724682T patent/DE69724682T2/de not_active Revoked
- 1997-03-18 EP EP97104590A patent/EP0796622B1/de not_active Revoked
- 1997-03-18 DK DK97104590T patent/DK0796622T3/da active
- 1997-03-18 ES ES97104590T patent/ES2206622T3/es not_active Expired - Lifetime
- 1997-03-18 PT PT97104590T patent/PT796622E/pt unknown
- 1997-03-18 AT AT97104590T patent/ATE249233T1/de not_active IP Right Cessation
2004
- 2004-12-20 US US11/016,680 patent/USRE40119E1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE69724682T2 (de)	2004-07-15
EP0796622B1 (de)	2003-09-10
USRE40119E1 (en)	2008-02-26
DK0796622T3 (da)	2004-01-12
ES2206622T3 (es)	2004-05-16
US5691314A (en)	1997-11-25
EP0796622A2 (de)	1997-09-24
EP0796622A3 (de)	1999-02-24
DE69724682D1 (de)	2003-10-16
PT796622E (pt)	2003-12-31

Similar Documents

Publication	Publication Date	Title
DE69724682D1 (de)	2003-10-16	Verwendung von Gonadotropin releasing Hormon Analogen oder änlichen Verbindungen zur Herstellung von pharmazeutischen Zubereitungen als Zusatz für invasiver Behandlung von Karzinomen
ATE222489T1 (de)	2002-09-15	Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren
IL127384A0 (en)	1999-10-28	Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
DE69022722D1 (de)	1995-11-02	Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen.
EE05025B1 (et)	2008-06-16	Fumaarhappe derivaadid kasutamiseks transplantaadivastase reaktsiooni raviks
ATE73334T1 (de)	1992-03-15	Antioestrogenes arzneimittel zur perkutanen verabreichung.
DE69433889D1 (de)	2004-08-12	Anwendung von 1,2,4-benzotriazinoxiden zur Herstellung eines Arzneimittels zur Behandlung von Tumoren
UA42747C2 (uk)	2001-11-15	Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
ATE106730T1 (de)	1994-06-15	Antigestagen- und antiöstrogenwirksame verbindungen zur behandlung hormonabhängiger tumoren.
JP2003524577A5 (de)	2006-02-23
SE8802569D0 (sv)	1988-07-08	Improvements in or relation to somatostatins
DE69914084D1 (de)	2004-02-12	Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
DE69332353D1 (de)	2002-11-07	Verwendung von inhibitoren der synthese von fettsäuren zur behandlung von krebs
ES2017808A6 (es)	1991-03-01	Un metodo para prepara una composicion para inhibir el crecimiento indeseado o patologico de celulas o tejidos.
ATE131060T1 (de)	1995-12-15	Chenodeoxycholsäure oder ursodeoxycholsäure zur behandlung von erkrankungen der atmungsorgane.
EA199700241A1 (ru)	1998-02-26	Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
ATE124681T1 (de)	1995-07-15	Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE60005952T8 (de)	2004-11-04	Lösliche hla-g enthaltende zusammensetzungen zur behandlung entzündlicher hautkrankheiten
ID26965A (id)	2001-02-22	Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid
ATE181240T1 (de)	1999-07-15	Verwendung von somatostatinanalogen zur behandlung von melanomen
ATE428438T1 (de)	2009-05-15	Tcf-ii enthaltende medizinische zusammensetzung
Fine et al.	1988	Hypersensitivity dermatitis following suction-assisted lipectomy: a complication of local anesthetic
ATE306278T1 (de)	2005-10-15	Behandlung von knochenleiden mit adrenomedullin
DE3575732D1 (de)	1990-03-08	Verwendung von gonadoliberin und gonadoliberinagonisten zur herstellung einer pharmazeutischen zubereitung.
Mackay	1926	Radium in dermatology

Legal Events

Date

Code

Title

Description

2004-09-15

UEP

Publication of translation of european patent specification

Ref document number: 0796622

Country of ref document: EP

2008-09-15

RZN

Patent revoked